BIOPHARMA ENTREPRENEURS MUST NOT FALL IN LOVE WITH THEIR INVENTION, but rather set up a series of Go/NoGo decision points. I have seen too many scientific founders devote themselves blindly to their molecule, become blind to the adverse data, and in rare instances actually hide or lie about the adverse data (I have seen this three times in 25 years).
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022